Hospitals/Healthcare
Household
|
|

Knock-Out Technologies is developing highly effective solutions designed to kill many of the most dangerous pathogens in our environment. An independent laboratory result on our germicidal product, " Knock-Outs Big 6 Plus", has proven to provide a high level of disinfection against Staph aureus, Salmonella choleraesuis, Strep, e.Coli, Listeria, Pseudomonas aeruginosa, and Avian Influenza
Kills the Big 6 - And Keeps You Safe
The EPA grants disinfectant status to any solution which destroys the following 3 micro-organisms: Staph Aureus, Pseudomonas aeruginosa, and Salmonella Choleraesuis. Knock-Out Technologies' germicidal formula, which is currently undergoing EPA protocol testing, goes beyond this: it not only kills these 3 pathogens, but kills three other organisms as well: Listeria, Strep, and e.Coli.
Our unique formula departs from the norm in that it kills the Big 6 (Staph, Salmonella, Strep, e.Coli, Listeria and Pseudomonas) without being harmful to the user. Based entirely on natural and synthetic food grade components, including natural oils and potent phytochemicals, it has been found highly effective in EPA protocol tests conducted by an independent EPA licensed laboratory. For instance, initial tests showed a 100% kill rate for the big 6 for our germicidal formula on both hard and porous surfaces.
Knock-Out's Germicidal Cleaner Formula is non-carcinogenic. It is highly effective when used to clean and sanitize hard or porous surfaces. Our target markets include:
- Hospitals, Nursing Homes, Clinics
- Doctors Offices
- Medical Instruments
- Emergency equipment
- Restaurants
- Industrial/Commercial public areas
Knock-Out Technologies' germicidal products are designed to create highly safe disinfection that destroys germs, not people.
Contact us for further information about our revolutionary germicidal cleaner.
"New Formula Knocks Out Anthrax Safely"
Knock-Out Technology's sporicidal formula has been shown to completely eradicate the EPA organism for anthrax (Bacillus Anthracus) introduced into closed environments on both hard and porous surfaces, while remaining safe for humans. Its innovative formulation utilizes all food-grade components (instead of toxic chemicals currently in use) making toxic clean-up and anthrax prevention much safer for both people and the environment.
Powerful enough to stop anthrax, yet safe for the environment and those who handle it, this new product is an answer to effective protection against this potentially lethal pathogen.
Trimycin
The Trimycin product is currently undergoing testing on the Tuberculosis organism (Mycobacterium Tuberculosis) at the National Center for Genetic Engineering
and Biotechnology (BIOTEC), a branch of the National Science and Technology Development
Agency (NSTDA) located in the greater Bangkok metropolitan area of Thailand. The World
Health Organizations’ Global Plan to Stop TB 2006-2015 expects to treat 50 million people
for Tuberculosis and save 14 million lives, at a cost of US $56 billion over the next 10
years (Stop TB Partnership; World Health Organization).
Auromoxin
The Auromoxin product is currently undergoing testing on live
tissue samples inoculated with Malaria (Plasmodium Falciparum) at BIOTEC in Thailand. In Africa alone, Malaria
accounts for approximately 40% of total government spending on public health, including direct costs on health
facilities, mosquito control, and malaria-related education and research (The Roll Back Malaria Partnership; World
Health Organization.)
Occusyn
The Occusyn product for Lyme disease is currently being researched
in clinical trials. Initial results have been encouraging. Lyme disease costs society about $1 billion per year,
for unnecessary or inappropriate medical care, lost productivity, legal fees, and other direct/indirect expenses
(Irwin T. Vanderhoof, PhD, CLU et al. (1993) Lyme disease: The cost to society. Contingencies).
OraPhyte
The OraPhyte product was designed to combat plant-parasitic
nematodes, which are microscopic worms that cause an estimated crop loss of $100 billion globally (U.S. Department
of Agriculture, Mennan, S., Handoo, Z.A. (2006) Nematropica). The Company anticipates significant information on
the ongoing testing of the OraPhyte product.
Immune Booster Bar
The Immune Booster Bar is formulated and ready for
packaging and distribution. The Company is hopeful for an early 2007 launch of this product which will be the
Company’s first entry into the functional food market. The market size for food bars alone is estimated to be $3
billion per year and growing rapidly.
Cinnechol™
Multi-faceted nutritional supplement designed to naturally reduce
total cholesterol levels without side effects now formulated and ready for launch
Contact us for further information about our revolutional germicidal cleaner which is currently awaiting EPA registration.
|